|
FR2850282B1
(fr)
|
2003-01-27 |
2007-04-06 |
Jerome Asius |
Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
|
|
WO2005027906A1
(en)
*
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Transscleral delivery
|
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
EP2594259A1
(en)
|
2004-08-04 |
2013-05-22 |
Brookwood Pharmaceuticals, Inc. |
Methods for manufacturing delivery devices and devices thereof
|
|
WO2006039336A2
(en)
*
|
2004-10-01 |
2006-04-13 |
Ramscor, Inc. |
Conveniently implantable sustained release drug compositions
|
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
CA2587921A1
(fr)
|
2004-11-22 |
2006-05-26 |
Centre National De La Recherche Scientifique |
Netrine 4 mutee, ses fragments et leur utilisation comme medicaments
|
|
GB2438544A
(en)
*
|
2005-02-09 |
2007-11-28 |
Cooper Internat Corp |
Liquid formulations for treatment of diseases or conditions
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
WO2007019427A2
(en)
*
|
2005-08-08 |
2007-02-15 |
Massachusetts Eye & Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
|
EP1962586B1
(en)
*
|
2005-12-22 |
2017-07-12 |
Oakwood Laboratories L.L.C. |
Sublimable sustained release delivery system and method of making same
|
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
|
US8591531B2
(en)
|
2006-02-08 |
2013-11-26 |
Tyrx, Inc. |
Mesh pouches for implantable medical devices
|
|
MX2008010126A
(es)
|
2006-02-08 |
2010-02-22 |
Tyrx Pharma Inc |
Protesis de malla temporalmente rigidizadas.
|
|
CA2635797C
(en)
|
2006-02-09 |
2015-03-31 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
|
WO2007100609A2
(en)
*
|
2006-02-24 |
2007-09-07 |
Albert Einstein College Of Medicine Of Yeshiva University |
Electron transfer through glassy matrices
|
|
CN101443004B
(zh)
*
|
2006-03-23 |
2013-03-06 |
参天制药株式会社 |
用于与血管通透性有关的疾病或病症的制剂
|
|
US20070265329A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Devang Shah T |
Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
|
|
EP1864668B1
(en)
*
|
2006-06-01 |
2012-11-21 |
Novagali Pharma S.A. |
Use of prodrugs for ocular intravitreous administration
|
|
MX2009001114A
(es)
|
2006-08-09 |
2009-02-10 |
Intarcia Therapeutics Inc |
Sistemas de suministro osmotico y ensambles de piston.
|
|
US20100179175A1
(en)
*
|
2006-08-23 |
2010-07-15 |
Sivak Jeremy M |
Use of pkc inhibitors in ocular diseases
|
|
US8821943B2
(en)
*
|
2006-09-12 |
2014-09-02 |
Board Of Regents Of The University Of Nebraska |
Methods and compositions for targeted delivery of therapeutic agents
|
|
US20080138350A1
(en)
*
|
2006-10-20 |
2008-06-12 |
Bennett Michael D |
Process for use of fluoroquinolones to reduce or modulate inflammation due to eye disease or ophthalmic surgery
|
|
EP2078052B1
(en)
*
|
2006-10-31 |
2010-07-28 |
Surmodics Pharmaceuticals, Inc. |
Spheronized polymer particles
|
|
US9023114B2
(en)
|
2006-11-06 |
2015-05-05 |
Tyrx, Inc. |
Resorbable pouches for implantable medical devices
|
|
CN101563068B
(zh)
|
2006-12-18 |
2013-03-20 |
武田药品工业株式会社 |
缓释组合物和其制备方法
|
|
CA3201293A1
(en)
*
|
2007-03-07 |
2008-09-12 |
Abraxis Bioscience, Llc |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
|
AU2008260447B2
(en)
*
|
2007-06-01 |
2013-10-10 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
|
US20080317805A1
(en)
*
|
2007-06-19 |
2008-12-25 |
Mckay William F |
Locally administrated low doses of corticosteroids
|
|
KR101760139B1
(ko)
*
|
2007-06-29 |
2017-07-31 |
클라렌슈 피티와이 리미티드 |
안투여를 통한 신경 또는 신경정신 장애의 치료 또는 예방용 약학 조성물
|
|
KR100882817B1
(ko)
*
|
2007-07-20 |
2009-02-10 |
숙명여자대학교산학협력단 |
보툴리늄 독소를 유효성분으로 포함하는 지방세포 생착증진용 약학적 조성물
|
|
US8124601B2
(en)
*
|
2007-11-21 |
2012-02-28 |
Bristol-Myers Squibb Company |
Compounds for the treatment of Hepatitis C
|
|
US20110097408A1
(en)
*
|
2007-12-10 |
2011-04-28 |
O'malley Bert W |
Chitosan-based matrices and uses thereof
|
|
US8728528B2
(en)
|
2007-12-20 |
2014-05-20 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
|
EP2244693B1
(de)
|
2008-01-18 |
2012-05-16 |
Horst Kief |
Mittel zur intraartikulären injektion
|
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
US20090226547A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Gilbard Jeffrey P |
Dietary Supplement For Eye Health
|
|
US9132119B2
(en)
*
|
2008-04-18 |
2015-09-15 |
Medtronic, Inc. |
Clonidine formulation in a polyorthoester carrier
|
|
US8883768B2
(en)
*
|
2008-04-18 |
2014-11-11 |
Warsaw Orthopedic, Inc. |
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
|
US9125917B2
(en)
*
|
2008-04-18 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Fluocinolone formulations in a biodegradable polymer carrier
|
|
US20100015240A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Danielle Biggs |
Process for preparing microparticles containing bioactive peptides
|
|
WO2010011597A2
(en)
*
|
2008-07-22 |
2010-01-28 |
Mayo Foundation For Medical Education And Research |
Treatment of obesity and related disorders
|
|
GB2479069B
(en)
*
|
2008-09-24 |
2012-07-25 |
Stabilitech Ltd |
Method for preserving polypeptides using a sugar and polyethyleneimine
|
|
US20110212127A1
(en)
*
|
2008-09-24 |
2011-09-01 |
Stabilitech Ltd. |
Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine
|
|
EP2350012B1
(en)
*
|
2008-10-06 |
2017-06-28 |
The Johns Hopkins University |
Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
|
|
CN102238949A
(zh)
|
2008-10-09 |
2011-11-09 |
拉姆斯科股份有限公司 |
治疗干眼综合征的组合物和方法
|
|
AT507187B1
(de)
|
2008-10-23 |
2010-03-15 |
Helmut Dr Buchberger |
Inhalator
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
CA3045436C
(en)
|
2009-01-29 |
2025-10-07 |
Forsight Vision4 Inc |
Posterior segment drug delivery
|
|
WO2011031476A2
(en)
*
|
2009-08-25 |
2011-03-17 |
Emory University |
Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation
|
|
DK2462246T3
(da)
|
2009-09-28 |
2017-11-06 |
Intarcia Therapeutics Inc |
Hurtig etablering og/eller afslutning af væsentlig steady-state-lægemiddelafgivelse
|
|
US20110097380A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Clonidine formulations having antimicrobial properties
|
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
US10206960B2
(en)
|
2010-03-31 |
2019-02-19 |
Stabilitech Biopharma Ltd |
Stabilisation of viral particles
|
|
HUE042330T2
(hu)
|
2010-03-31 |
2019-06-28 |
Stabilitech Biopharma Ltd |
Módszer alumínium adjuvánsok és alumíniummal adjuvált vakcinák megóvására
|
|
AU2011234264B2
(en)
|
2010-03-31 |
2016-02-04 |
Stabilitech Ltd |
Excipients for stabilising viral particles, polypeptides or biological material
|
|
DE102010013898A1
(de)
*
|
2010-04-01 |
2011-10-06 |
Acino Ag |
Implantatskanüle mit Implantat und Verfahren zum Befestigen von Implantaten in einer Injektionskanüle
|
|
CN103153316B
(zh)
|
2010-08-05 |
2015-08-19 |
弗赛特影像4股份有限公司 |
组合药物递送方法和设备
|
|
HUE057267T2
(hu)
|
2010-08-05 |
2022-05-28 |
Forsight Vision4 Inc |
Berendezés szem kezelésére
|
|
HUE054113T2
(hu)
|
2010-08-05 |
2021-08-30 |
Forsight Vision4 Inc |
Injekciós készülék gyógyszerbejuttatáshoz
|
|
CN101972236A
(zh)
*
|
2010-10-13 |
2011-02-16 |
北京诚创康韵医药科技有限公司 |
一种含吡非尼酮的缓释制剂
|
|
EP2640360A2
(en)
|
2010-11-19 |
2013-09-25 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
WO2012097258A2
(en)
*
|
2011-01-15 |
2012-07-19 |
The Regents Of The University Of California |
Formulations for the prevention and treatment of wolbachia-related disease
|
|
CN103491815B
(zh)
|
2011-02-11 |
2016-01-20 |
巴特马克有限公司 |
吸入器组件
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
RS60051B1
(sr)
*
|
2011-06-10 |
2020-04-30 |
Ramscor Inc |
Formulacije sa produženim oslobađanjem za isporuku proteina u oko i postupci njihove pripreme
|
|
US10398592B2
(en)
|
2011-06-28 |
2019-09-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
SI2755600T1
(sl)
|
2011-09-16 |
2021-08-31 |
Forsight Vision4, Inc. |
Naprava za izmenjavo tekočine
|
|
GB201117233D0
(en)
|
2011-10-05 |
2011-11-16 |
Stabilitech Ltd |
Stabilisation of polypeptides
|
|
US20130190839A1
(en)
*
|
2012-01-20 |
2013-07-25 |
Jane Rapsey |
Drug delivery using a sacrificial host
|
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
KR102154880B1
(ko)
|
2012-05-03 |
2020-09-10 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
US9056057B2
(en)
|
2012-05-03 |
2015-06-16 |
Kala Pharmaceuticals, Inc. |
Nanocrystals, compositions, and methods that aid particle transport in mucus
|
|
UA116217C2
(uk)
|
2012-10-09 |
2018-02-26 |
Санофі |
Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
|
|
US20140105956A1
(en)
*
|
2012-10-11 |
2014-04-17 |
Rupak BANERJEE |
Biodegradable polymer based microimplant for ocular drug delivery
|
|
CN105164204A
(zh)
|
2012-11-21 |
2015-12-16 |
路易斯维尔大学研究基金会 |
用于降低氧化损伤的组合物和方法
|
|
PT2934568T
(pt)
|
2012-12-21 |
2018-01-04 |
Sanofi Sa |
Agonistas duplos de glp1/gip ou trigonais de glp1/gip/glucagina
|
|
US9283231B2
(en)
|
2013-01-31 |
2016-03-15 |
Icon Bioscience, Inc. |
Sustained release formulations for the treatment of intraocular pressure of glaucoma
|
|
AU2014216178B2
(en)
|
2013-02-15 |
2018-06-28 |
KALA BIO, Inc. |
Therapeutic compounds and uses thereof
|
|
US9688688B2
(en)
|
2013-02-20 |
2017-06-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
|
|
EP2958895B1
(en)
|
2013-02-20 |
2020-08-19 |
Kala Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
|
AU2014236455B2
(en)
|
2013-03-14 |
2018-07-12 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
ES2972168T3
(es)
|
2013-03-28 |
2024-06-11 |
Forsight Vision4 Inc |
Implante oftálmico para administración de sustancias terapéuticas
|
|
WO2014167327A1
(en)
*
|
2013-04-09 |
2014-10-16 |
Cresset Biomolecular Discovery Ltd |
The treatment of inflammatory disorders
|
|
JP6530744B2
(ja)
*
|
2013-05-24 |
2019-06-12 |
アイコン バイオサイエンス インコーポレイテッド |
白内障手術後の炎症における徐放性デキサメタゾンの使用
|
|
CA2919892C
(en)
|
2013-08-12 |
2019-06-18 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded immediate release abuse deterrent pill
|
|
CA2928658A1
(en)
|
2013-11-01 |
2015-05-07 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
US9890173B2
(en)
|
2013-11-01 |
2018-02-13 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
TW201609796A
(zh)
|
2013-12-13 |
2016-03-16 |
賽諾菲公司 |
非醯化之艾塞那肽－４（ｅｘｅｎｄｉｎ－４）胜肽類似物
|
|
TW201609795A
(zh)
|
2013-12-13 |
2016-03-16 |
賽諾菲公司 |
作為雙重ｇｌｐ－１／ｇｉｐ受體促效劑的艾塞那肽－４（ｅｘｅｎｄｉｎ－４）胜肽類似物
|
|
TW201609797A
(zh)
|
2013-12-13 |
2016-03-16 |
賽諾菲公司 |
雙重ｇｌｐ－１／升糖素受體促效劑
|
|
TW201609799A
(zh)
|
2013-12-13 |
2016-03-16 |
賽諾菲公司 |
雙重ｇｌｐ－１／ｇｉｐ受體促效劑
|
|
US9492444B2
(en)
|
2013-12-17 |
2016-11-15 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
US10172797B2
(en)
|
2013-12-17 |
2019-01-08 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
TW201625669A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
衍生自艾塞那肽－４（Ｅｘｅｎｄｉｎ－４）之肽類雙重ＧＬＰ－１／升糖素受體促效劑
|
|
TW201625668A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物
|
|
TW201625670A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
衍生自ｅｘｅｎｄｉｎ－４之雙重ｇｌｐ－１／升糖素受體促效劑
|
|
GB201406569D0
(en)
|
2014-04-11 |
2014-05-28 |
Stabilitech Ltd |
Vaccine compositions
|
|
EP3131532A1
(de)
|
2014-04-16 |
2017-02-22 |
Veyx-Pharma GmbH |
Veterinärpharmazeutische zusammensetzung und deren verwendung
|
|
US9932381B2
(en)
|
2014-06-18 |
2018-04-03 |
Sanofi |
Exendin-4 derivatives as selective glucagon receptor agonists
|
|
WO2016011191A1
(en)
|
2014-07-15 |
2016-01-21 |
Forsight Vision4, Inc. |
Ocular implant delivery device and method
|
|
DK3169315T3
(da)
|
2014-07-17 |
2020-08-10 |
Pharmaceutical Manufacturing Res Services In |
Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
|
|
ES2969374T3
(es)
|
2014-07-30 |
2024-05-17 |
Massachusetts Eye & Ear Infirmary |
Metotrexato para la vitreorretinopatía proliferativa
|
|
CA2957548A1
(en)
|
2014-08-08 |
2016-02-11 |
Forsight Vision4, Inc. |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
|
EA201790391A1
(ru)
*
|
2014-08-15 |
2017-06-30 |
Пиксарбайо Корпорейшн |
Композиции для ингибирования воспаления у субъекта с повреждением спинного мозга и способы их применения
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
EP3209282A4
(en)
|
2014-10-20 |
2018-05-23 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extended release abuse deterrent liquid fill dosage form
|
|
GB2535427A
(en)
|
2014-11-07 |
2016-08-24 |
Nicoventures Holdings Ltd |
Solution
|
|
BR112017009660A2
(pt)
|
2014-11-10 |
2017-12-19 |
Forsight Vision4 Inc |
dispositivos de administração de fármacos expansíveis e métodos de utilização
|
|
EP3256136A4
(en)
|
2015-02-09 |
2018-11-21 |
University Of Louisville Research Foundation, Inc. |
Ophthalmic compositions and methods for reducing oxidative damage to an eye lens
|
|
CA2979971A1
(en)
*
|
2015-03-18 |
2016-09-22 |
Santen Pharmaceutical Co., Ltd. |
Sustained-release pharmaceutical composition
|
|
US10925639B2
(en)
|
2015-06-03 |
2021-02-23 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
|
AR105319A1
(es)
|
2015-06-05 |
2017-09-27 |
Sanofi Sa |
Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
|
|
TW201706291A
(zh)
|
2015-07-10 |
2017-02-16 |
賽諾菲公司 |
作為選擇性肽雙重ｇｌｐ－１／升糖素受體促效劑之新毒蜥外泌肽（ｅｘｅｎｄｉｎ－４）衍生物
|
|
GB2542838B
(en)
|
2015-10-01 |
2022-01-12 |
Nicoventures Trading Ltd |
Aerosol provision system
|
|
CN105496947A
(zh)
*
|
2015-11-19 |
2016-04-20 |
苏州桓晨医疗科技有限公司 |
一种药物缓释制剂
|
|
JP6912475B2
(ja)
|
2015-11-20 |
2021-08-04 |
フォーサイト・ビジョン フォー・インコーポレーテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ４， Ｉｎｃ． |
持続放出性薬物送達機器用の多孔質構造体
|
|
AR108177A1
(es)
|
2016-04-05 |
2018-07-25 |
Forsight Vision4 Inc |
Dispositivos de suministro de fármacos oculares implantables
|
|
MA53353A
(fr)
|
2016-05-16 |
2021-06-09 |
Intarcia Therapeutics Inc |
Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
WO2017218284A1
(en)
*
|
2016-06-13 |
2017-12-21 |
Massachusetts Eye And Ear Infirmary |
Local orbital therapy for thyroid eye disease
|
|
US10682340B2
(en)
|
2016-06-30 |
2020-06-16 |
Durect Corporation |
Depot formulations
|
|
EP3478285A4
(en)
|
2016-06-30 |
2020-07-22 |
Durect Corporation |
DEPOSIT FORMULATIONS
|
|
CA3036340A1
(en)
|
2016-09-08 |
2018-03-15 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
CA3036065A1
(en)
|
2016-09-08 |
2018-03-15 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
AU2017324713B2
(en)
|
2016-09-08 |
2020-08-13 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
HUE046449T2
(hu)
|
2016-09-13 |
2020-03-30 |
Allergan Inc |
Stabilizált, nem fehérje eredetû, clostridiális toxin készítmények
|
|
KR20190104039A
(ko)
|
2017-01-03 |
2019-09-05 |
인타르시아 세라퓨틱스 인코포레이티드 |
Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
|
|
GB2562241B
(en)
|
2017-05-08 |
2022-04-06 |
Stabilitech Biopharma Ltd |
Vaccine compositions
|
|
CN115607358A
(zh)
|
2017-11-21 |
2023-01-17 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
|
JP2021508740A
(ja)
|
2018-01-02 |
2021-03-11 |
アルマタ・ファーマシューティカルズ・インコーポレーテッド |
Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ感染症を処置するための治療的バクテリオファージ組成物
|
|
JP7257342B2
(ja)
|
2018-02-08 |
2023-04-13 |
テルモ株式会社 |
医療器具およびこれを用いた癒合促進デバイス
|
|
US11065003B2
(en)
|
2018-03-19 |
2021-07-20 |
Terumo Kabushiki Kaisha |
Treatment method for joining biological organs
|
|
CA3097927A1
(en)
|
2018-05-01 |
2019-11-07 |
Chibi, Inc. |
Liquid depot for non-invasive sustained delivery of agents to the eye
|
|
MX2020011535A
(es)
*
|
2018-05-01 |
2020-11-24 |
Chibi Inc |
Formulacion de gotas para ojos y metodos para la liberacion sostenida de medicamento a la retina.
|
|
WO2020067372A1
(ja)
|
2018-09-27 |
2020-04-02 |
テルモ株式会社 |
癒合促進デバイス
|
|
CN112638287A
(zh)
|
2018-09-27 |
2021-04-09 |
泰尔茂株式会社 |
愈合促进器具以及医疗设备
|
|
CN113573666A
(zh)
|
2019-03-28 |
2021-10-29 |
泰尔茂株式会社 |
愈合促进器具
|
|
CN113573747B
(zh)
|
2019-03-28 |
2023-02-24 |
泰尔茂株式会社 |
医疗器具
|
|
CN113646016B
(zh)
|
2019-03-28 |
2023-07-11 |
泰尔茂株式会社 |
医疗器械
|
|
CN113490458A
(zh)
|
2019-03-28 |
2021-10-08 |
泰尔茂株式会社 |
愈合促进设备
|
|
WO2021051003A1
(en)
|
2019-09-13 |
2021-03-18 |
Aldeyra Therapeutics, Inc. |
Ophthalmic formulations of methotrexate
|
|
US11911499B2
(en)
|
2019-11-07 |
2024-02-27 |
Resurge Therapeutics, Inc. |
System and method for prostate treatment
|
|
CN113262302B
(zh)
*
|
2020-02-17 |
2022-12-09 |
湖州惠中济世生物科技有限公司 |
可注射长效半固体凝胶制剂
|
|
WO2021247208A1
(en)
*
|
2020-06-01 |
2021-12-09 |
Ads Therapeutics Llc |
Topical ophthalmological compositions and methods for treating abnormal angiogenesis
|
|
JP2023532778A
(ja)
*
|
2020-07-07 |
2023-07-31 |
デルシテック オサケユイチア |
シリカハイドロゲルコンポジットおよびその使用
|
|
FI20215186A1
(en)
*
|
2021-02-19 |
2022-08-20 |
Rebio Tech Oy |
Compositions for ophthalmic treatment
|
|
US11197819B1
(en)
*
|
2021-04-09 |
2021-12-14 |
Drug Delivery Company, Llc |
Extended release bioabsorbable subcutaneous medicinal dosage delivery implant system
|
|
CN115463217B
(zh)
*
|
2021-06-11 |
2024-03-12 |
深圳埃格林医药有限公司 |
己酸羟孕酮在增强肿瘤治疗效果中的应用
|
|
JPWO2023032692A1
(enExample)
|
2021-09-03 |
2023-03-09 |
|
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
US11957654B2
(en)
|
2022-01-29 |
2024-04-16 |
Resurge Therapeutics, Inc. |
Treating benign prostatic hyperplasia
|
|
US11974979B2
(en)
|
2022-01-29 |
2024-05-07 |
Resurge Therapeutics, Inc. |
Treatments for benign prostatic hyperplasia
|
|
US11911385B1
(en)
|
2022-12-14 |
2024-02-27 |
Aldeyra Therapeutics, Inc. |
Methotrexate treatment methods
|
|
WO2025147589A1
(en)
|
2024-01-05 |
2025-07-10 |
Osanni Bio, Inc. |
Implants, compositions, and methods for treating retinal diseases and disorders
|
|
CN118388331B
(zh)
*
|
2024-05-07 |
2025-05-16 |
山东极地医药科技有限公司 |
一种羟基丙酮的生产工艺
|